SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 102 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $4,460,000 | +1.4% | 400,000 | 0.0% | 0.09% | -2.3% |
Q2 2017 | $4,400,000 | +534.9% | 400,000 | +523.8% | 0.09% | +252.0% |
Q4 2016 | $693,000 | -81.6% | 64,127 | -82.6% | 0.02% | -78.4% |
Q3 2016 | $3,770,000 | +8.5% | 367,800 | +38.3% | 0.12% | +1.8% |
Q2 2016 | $3,474,000 | +0.7% | 265,971 | -15.2% | 0.11% | +15.2% |
Q1 2016 | $3,450,000 | +31.6% | 313,637 | +10.2% | 0.10% | +59.7% |
Q4 2015 | $2,621,000 | +144.7% | 284,545 | +84.5% | 0.06% | +82.4% |
Q3 2015 | $1,071,000 | -69.9% | 154,266 | -57.5% | 0.03% | -64.9% |
Q2 2015 | $3,564,000 | -5.9% | 362,898 | -15.1% | 0.10% | +1.0% |
Q1 2015 | $3,787,000 | -28.9% | 427,472 | -29.0% | 0.10% | -17.9% |
Q4 2014 | $5,328,000 | +8.5% | 601,891 | -15.4% | 0.12% | +4.5% |
Q3 2014 | $4,911,000 | +340.1% | 711,369 | +221.3% | 0.11% | +300.0% |
Q4 2013 | $1,116,000 | -35.7% | 221,369 | -35.3% | 0.03% | -28.2% |
Q3 2013 | $1,735,000 | +325.2% | 342,136 | +316.0% | 0.04% | +254.5% |
Q2 2013 | $408,000 | – | 82,251 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |